{"DataElement":{"publicId":"3290640","version":"1","preferredName":"Preoperative Neoadjuvant Therapy Type","preferredDefinition":"Name of the preoperative neoadjuvant modality administered to a patient.","longName":"3290618v1.0:3290638v1.2","context":"BOLD","contextVersion":"1","DataElementConcept":{"publicId":"3290618","version":"1","preferredName":"Preoperative Neoadjuvant Therapy Occurrence","preferredDefinition":"neoadjuvant therapy, as treatment designed to be used as a first step toward shrinking the cancer and in evaluating response to drugs and other agents._An instance of something happening, such as an event or incident._Relating to or occurring during the period immediately before a surgical operation.","longName":"2759145v1.0:2234856v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2759145","version":"1","preferredName":"Preoperative Neoadjuvant Therapy","preferredDefinition":"Relating to or occurring during the period immediately before a surgical operation. :Treatment designed to be used as a first step toward shrinking the cancer and in evaluating response to drugs and other agents. Induction therapy is followed by additional therapy to eliminate whatever cancer remains.","longName":"C54732:C15665","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Preoperative","conceptCode":"C54732","definition":"Relating to or occurring during the period immediately before a surgical operation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoadjuvant Therapy","conceptCode":"C15665","definition":"Therapy administered prior to the primary treatment for the purpose of making the primary treatment more effective.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F7ADEBF-049A-73CB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-12","modifiedBy":"ONEDATA","dateModified":"2008-06-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2234856","version":"1","preferredName":"Occurrence","preferredDefinition":"Occurrence; an instance of something happening.","longName":"C25275","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Occurrence","conceptCode":"C25275","definition":"An instance of something happening, such as an event or incident.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9860F29-72B8-7421-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-14","modifiedBy":"ONEDATA","dateModified":"2005-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AEA1E06D-B1A9-4C91-E040-BB89AD434487","latestVersionIndicator":"Yes","beginDate":"2011-10-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-10-06","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3290638","version":"1.2","preferredName":"Neoadjuvant Therapy Type","preferredDefinition":"Treatment designed to be used as a first step toward shrinking the cancer and in evaluating response to drugs and other agents. Induction therapy is followed by additional therapy to eliminate whatever cancer remains._Type; a subdivision of a particular kind of thing.","longName":"3290638v1.2","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"20","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Radiation","valueDescription":"Radiation Therapy","ValueMeaning":{"publicId":"3282850","version":"1","preferredName":"Radiation Therapy","longName":"3282850","preferredDefinition":"Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Radiation Therapy","conceptCode":"C15313","definition":"Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD89FB60-A183-4AC0-E040-BB89AD4312AF","latestVersionIndicator":"Yes","beginDate":"2011-09-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E6AD2664-E377-EFD5-E040-BB89AD4335F4","beginDate":"2011-10-06","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2013-09-18","modifiedBy":"ONEDATA","dateModified":"2013-09-18","deletedIndicator":"No"},{"value":"Hormonal","valueDescription":"Hormone","ValueMeaning":{"publicId":"3290639","version":"1","preferredName":"Hormone","longName":"3290639","preferredDefinition":"Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hormone","conceptCode":"C2315","definition":"Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AEA1E06D-B20C-4C91-E040-BB89AD434487","latestVersionIndicator":"Yes","beginDate":"2011-10-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-10-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E6AD2664-E381-EFD5-E040-BB89AD4335F4","beginDate":"2011-10-06","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2013-09-18","modifiedBy":"ONEDATA","dateModified":"2013-09-18","deletedIndicator":"No"},{"value":"Chemotherapy","valueDescription":"Chemotherapy","ValueMeaning":{"publicId":"2570169","version":"1","preferredName":"Chemotherapy","longName":"2570169","preferredDefinition":"The use of synthetic or naturally-occurring chemicals for the treatment of diseases.  Although this term may be used to describe any therapy involving the use of chemical-based agents, it is most commonly used to refer to the variety of chemical-based agents employed to treat cancer.  Cancer chemotherapy works by arresting or killing the growth and spread of cancer cells.  Because cancer cells usually divide much faster than normal cells, they are often very sensitive to the inhibitory actions of chemotherapeutic agents.  Chemotherapy may also include agents that enhance immune function or alter hormonal activity. (NCI04)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chemotherapy","conceptCode":"C15632","definition":"The use of synthetic or naturally-occurring chemicals for the treatment of diseases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DF26-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"CLOHNES","dateModified":"2022-11-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E6AD2664-E38B-EFD5-E040-BB89AD4335F4","beginDate":"2011-10-06","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2013-09-18","modifiedBy":"ONEDATA","dateModified":"2013-09-18","deletedIndicator":"No"},{"value":"Targeted Therapy","valueDescription":"Targeted Therapy","ValueMeaning":{"publicId":"3623150","version":"1","preferredName":"Targeted Therapy","longName":"3623150","preferredDefinition":"A type of treatment that uses drugs or other substances, such as monoclonal antibodies, to identify and attack specific cancer cells. Targeted therapy may have fewer side effects than other types of cancer treatments.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Targeted Therapy","conceptCode":"C93352","definition":"A type of cancer treatment that uses testing and medication to more precisely identify and treat cancer. These treatments target and disable genes or proteins necessary to the proliferation of cancer cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CCB54008-9077-E649-E040-BB89AD436CAF","latestVersionIndicator":"Yes","beginDate":"2012-10-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-10-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E6AD2664-E395-EFD5-E040-BB89AD4335F4","beginDate":"2012-10-23","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2013-09-18","modifiedBy":"ONEDATA","dateModified":"2013-09-18","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2565695","version":"1","preferredName":"Unknown","longName":"2565695","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CDAC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-02-26","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-02-26","modifiedBy":"MMADDINENI","dateModified":"2024-02-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3074AE13-CB6F-7FCE-E050-BB89AD43781F","beginDate":"2016-04-14","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2016-04-14","modifiedBy":"ONEDATA","dateModified":"2016-04-14","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3290637","version":"1","preferredName":"Neoadjuvant Therapy Type","preferredDefinition":"Treatment designed to be used as a first step toward shrinking the cancer and in evaluating response to drugs and other agents. Induction therapy is followed by additional therapy to eliminate whatever cancer remains.:Type; a subdivision of a particular kind of thing.","longName":"C15665:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoadjuvant Therapy","conceptCode":"C15665","definition":"Therapy administered prior to the primary treatment for the purpose of making the primary treatment more effective.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AEA1E06D-B1DC-4C91-E040-BB89AD434487","latestVersionIndicator":"Yes","beginDate":"2011-10-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-10-06","modifiedBy":"ONEDATA","dateModified":"2011-10-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E6AD2664-E362-EFD5-E040-BB89AD4335F4","latestVersionIndicator":"Yes","beginDate":"2013-09-18","endDate":"2013-09-18","createdBy":"ZHANGWE","dateCreated":"2013-09-18","modifiedBy":"ZIEGLERK","dateModified":"2016-04-14","changeDescription":"A new version is created to change max from 12 to 20.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3461586","version":"1","longName":"BOLD:Breast Oncology Local Disease","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461590","version":"1","longName":"Surgery Elements","context":"NCIP"}]},{"publicId":"3886759","version":"1","longName":"Surgery Elements","context":"BOLD","ClassificationSchemeItems":[{"publicId":"3902142","version":"1","longName":"Surgery","context":"BOLD"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Type of Preoperative Therapy","type":"Preferred Question Text","description":"Type of Preoperative Therapy (check all that apply)","url":null,"context":"BOLD"}],"origin":"BOLD:Breast Oncology Local Disease Initiative","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"AEA1E06D-B239-4C91-E040-BB89AD434487","latestVersionIndicator":"Yes","beginDate":"2011-10-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-10-06","modifiedBy":"REEVESD","dateModified":"2016-09-06","changeDescription":"Curated to support Breast Oncology Local Disease (BOLD) Initiative","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}